BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu G, Luo Y, Wang H, Wang Y, Liu B, Wei J. Therapeutic bispecific antibodies against intracellular tumor antigens. Cancer Lett 2022;:215699. [PMID: 35487312 DOI: 10.1016/j.canlet.2022.215699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Laniel A, Marouseau É, Nguyen DT, Froehlich U, McCartney C, Boudreault PL, Lavoie C. Characterization of PGua(4), a Guanidinium-Rich Peptoid that Delivers IgGs to the Cytosol via Macropinocytosis. Mol Pharm 2023;20:1577-90. [PMID: 36781165 DOI: 10.1021/acs.molpharmaceut.2c00783] [Reference Citation Analysis]
2 Shi N, Zhou Y, Liu Y, Zhang R, Jiang X, Ren C, Gao X, Luo L. PD-1/LAG-3 bispecific antibody potentiates T cell activation and increases antitumor efficacy. Front Immunol 2022;13:1047610. [PMID: 36518768 DOI: 10.3389/fimmu.2022.1047610] [Reference Citation Analysis]
3 Tan Y, Cai J, Wang Z. Epsilon-caprolactone-modified polyethylenimine as a genetic vehicle for stem cell-based bispecific antibody and exosome synergistic therapy. Regen Biomater 2023;10:rbac090. [PMID: 36683744 DOI: 10.1093/rb/rbac090] [Reference Citation Analysis]
4 Li Y, Gopalakrishnan C, Wang J, Ramalingam R, Xu C, Han P. Glioblastoma Subtyping by Immuogenomics. Intelligent Computing Theories and Application 2022. [DOI: 10.1007/978-3-031-13829-4_10] [Reference Citation Analysis]